Chronic Inflammatory Demyelinating Polyneuropathy

Overview

Journal Curr Treat Options Neurol

Specialty Neurology

Date 2013 Apr 9

PMID 23564314

Citations 26

Authors

Mazen M Dimachkie

Richard J Barohn

Affiliations

Soon will be listed here.

Abstract

Chronic Inflammatory polyneuropathies are an important group of neuromuscular disorders that present chronically and progress over more than 8 weeks, being referred to as chronic inflammatory demyelinating polyneuropathy (CIDP). Despite tremendous progress in elucidating disease pathogenesis, the exact triggering event remains unknown. Our knowledge regarding diagnosis and management of CIDP and its variants continues to expand, resulting in improved opportunities for identification and treatment. Most clinical neurologists will be involved in the management of patients with these disorders, and should be familiar with available therapies for CIDP. We review the distinctive clinical, laboratory, and electro-diagnostic features that aid in diagnosis. We emphasize the importance of clinical patterns that define treatment responsiveness and the most appropriate therapies in order to improve prognosis.

Citing Articles

Shoulder Dysfunction and Quality of Life Following Modified Radical and Selective Neck Dissection: A Prospective Comparative Study.

Mishra A, Parida P, Bhoi S, Sahoo J, Samal D, Dash A Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3245-3255.

PMID: 39130289 PMC: 11306493. DOI: 10.1007/s12070-024-04659-y.

A Severe Case of Diabetic Lumbosacral Radiculoplexus Neuropathy: A Diagnosis of Exclusion.

Dao K, Leepakshi J, Abraham J, Aranguri C, Clarke M, Ly B Cureus. 2024; 16(6):e61969.

PMID: 38978950 PMC: 11230586. DOI: 10.7759/cureus.61969.

Hepatitis B Precipitating Neurological Complications: A Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Conundrum.

Krishnan G, Chandrasekar K, Natarajan G Cureus. 2024; 16(2):e53551.

PMID: 38445132 PMC: 10913701. DOI: 10.7759/cureus.53551.

A rare case of Balo's disease in a young adult: A clinical presentation and management.

Singh M, Almusleh A, Mandru G, Sahu S, Akuma O, Akuma C Clin Case Rep. 2024; 12(2):e8520.

PMID: 38344357 PMC: 10857917. DOI: 10.1002/ccr3.8520.

Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.

Lyou H, Chung Y, Kim M, Kim M, Jeon M, Kim S J Clin Neurol. 2024; 20(2):186-193.

PMID: 38171501 PMC: 10921045. DOI: 10.3988/jcn.2023.0055.

References

Hughes R, Gorson K, Cros D, Griffin J, Pollard J, Vallat J . Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2010; 74(8):651-7. DOI: 10.1212/WNL.0b013e3181d1a862. View

Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J . Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2005; 10(2):174-80. DOI: 10.1111/j.1085-9489.2005.0010207.x. View

Tackenberg B, Jelcic I, Baerenwaldt A, Oertel W, Sommer N, Nimmerjahn F . Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci U S A. 2009; 106(12):4788-92. PMC: 2660764. DOI: 10.1073/pnas.0807319106. View

Saperstein D, Katz J, Amato A, Barohn R . Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. 2001; 24(3):311-24. DOI: 10.1002/1097-4598(200103)24:3<311::aid-mus1001>3.0.co;2-a. View

Gorson K, Ropper A, Clark B, Dew 3rd R, Simovic D, Allam G . Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a. Neurology. 1998; 50(1):84-7. DOI: 10.1212/wnl.50.1.84. View

van den Bergh P, Hadden R, Bouche P, Cornblath D, Hahn A, Illa I . European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the.... Eur J Neurol. 2010; 17(3):356-63. DOI: 10.1111/j.1468-1331.2009.02930.x. View

Hodgkinson S, Pollard J, McLeod J . Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 1990; 53(4):327-30. PMC: 1014171. DOI: 10.1136/jnnp.53.4.327. View

Jann S, Bramerio M, Facchetti D, Sterzi R . Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up. J Neurol Neurosurg Psychiatry. 2008; 80(1):70-3. DOI: 10.1136/jnnp.2008.149013. View

Vallat J, Hahn A, Leger J, Cros D, Magy L, Tabaraud F . Interferon beta-1a as an investigational treatment for CIDP. Neurology. 2003; 60(8 Suppl 3):S23-8. DOI: 10.1212/wnl.60.8_suppl_3.s23. View

10.

Chaudhry V, Cornblath D, Griffin J, OBrien R, Drachman D . Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology. 2001; 56(1):94-6. DOI: 10.1212/wnl.56.1.94. View

11.

Bril V, Banach M, Dalakas M, Deng C, Donofrio P, Hanna K . Electrophysiologic correlations with clinical outcomes in CIDP. Muscle Nerve. 2010; 42(4):492-7. DOI: 10.1002/mus.21733. View

12.

Matsumuro K, Izumo S, Umehara F, Osame M . Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves. J Neurol Sci. 1994; 127(2):170-8. DOI: 10.1016/0022-510x(94)90070-1. View

13.

Sabatelli M, Mignogna T, Lippi G, Milone M, Di Lazzaro V, Tonali P . Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 1995; 58(5):638-9. PMC: 1073503. DOI: 10.1136/jnnp.58.5.638. View

14.

Muley S, Kelkar P, Parry G . Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Arch Neurol. 2008; 65(11):1460-4. DOI: 10.1001/archneur.65.11.1460. View

15.

Thaisetthawatkul P, Logigian E, Herrmann D . Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology. 2002; 59(10):1526-32. DOI: 10.1212/01.wnl.0000034172.47882.20. View

16.

Bosboom W, van den Berg L, Franssen H, Giesbergen P, Flach H, van Putten A . Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain. 2001; 124(Pt 12):2427-38. DOI: 10.1093/brain/124.12.2427. View

17.

Oyama Y, Sufit R, Loh Y, Statkute L, Yaung K, Quigley K . Nonmyeloablative autologous hematopoietic stem celltransplantation for refractory CIDP. Neurology. 2007; 69(18):1802-3. DOI: 10.1212/01.wnl.0000277266.53449.8b. View

18.

Mendell J, Barohn R, Freimer M, Kissel J, King W, Nagaraja H . Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2001; 56(4):445-9. DOI: 10.1212/wnl.56.4.445. View

19.

Labate A, Morelli M, Palamara G, Pirritano D, Quattrone A . Tacrolimus-induced polyneuropathy after heart transplantation. Clin Neuropharmacol. 2010; 33(3):161-2. DOI: 10.1097/WNF.0b013e3181dc4f43. View

20.

Chi L, Wang H, Wang W . Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2008; 13(1):54-63. DOI: 10.1111/j.1529-8027.2008.00158.x. View